Verizon Communications awarded Malady Kyle 122 derivative securities at $14.26 per share on 2026-09-10. Kyle’s resulting holding was 424,384 derivative securities, and the award represented about 0.0% of that position. For investors, the figures identify the transaction’s size and Kyle’s resulting derivative-securities position.

Key Highlights

  • Malady Kyle held 424,384 Verizon derivative securities after the transaction.
  • The award represented about 0.0% of Kyle’s resulting derivative-securities holding.
  • Verizon Communications reported the transaction through a Form 4 insider statement.

VERIZON COMMUNICATIONS INC (NYSE: VZ) awarded Malady Kyle 122 derivative securities at $14.26 per share. The transaction adds to Kyle’s derivative-securities position at Verizon Communications.

Kyle’s Post-Transaction Holding Malady Kyle serves as EVP and Group CEO-VZ Business.

The award was dated 10 September 2026 and carried SEC transaction code A, which denotes an award or grant. Kyle held 424,384 derivative securities after the transaction. The award represented about 0.0% of that resulting holding. Verizon Communications identified the transaction in a Form 4 insider statement.